LigaChem Biosciences Company Description

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.

The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs.

It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs.

The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024.

LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.

LigaChem Biosciences Inc.

Country	South Korea
Founded	2006
Industry	Biological Products, Except Diagnostic Substances
Employees	157
CEO	Yong Kim

Contact Details

Address: 10, Gukjegwahak 10-ro Daejeon, 34002 South Korea
Phone	82 4 2861 0688
Website	legochembio.com

Stock Details

Ticker Symbol	141080
Exchange	KOSDAQ
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	2836

Key Executives

Name	Position
Yong Kim	Chief Executive Officer
Sejin Park	Chief Financial Officer
Sejin Park	Chief Operating Officer